SMIM: A unified framework of survival sensitivity analysis using multiple imputation and martingale
暂无分享,去创建一个
Shu Yang | Guanghan Frank Liu | Yilong Zhang | Qian Guan | Shu Yang | G. Liu | Yilong Zhang | Qian Guan
[1] A A Tsiatis,et al. Causal Inference on the Difference of the Restricted Mean Lifetime Between Two Groups , 2001, Biometrics.
[2] Shu Yang,et al. A note on multiple imputation for method of moments estimation , 2015, 1508.06977.
[3] J. Robins,et al. Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men. , 2000, Epidemiology.
[4] W. Fuller,et al. Quantile Estimation with a Complex Survey Design , 1991 .
[5] C. F. Wu. JACKKNIFE , BOOTSTRAP AND OTHER RESAMPLING METHODS IN REGRESSION ANALYSIS ' BY , 2008 .
[6] A Unified Framework for Causal Inference with Multiple Imputation Using Martingale , 2019, 1911.04663.
[7] Lena Osterhagen,et al. Multiple Imputation For Nonresponse In Surveys , 2016 .
[8] Michael G. Kenward,et al. Information‐anchored sensitivity analysis: theory and application , 2018, Journal of the Royal Statistical Society. Series A,.
[9] Donglin Zeng,et al. Partially Linear Additive Hazards Regression With Varying Coefficients , 2008 .
[10] Patrick Royston,et al. Restricted mean survival time: an alternative to the hazard ratio for the design and analysis of randomized trials with a time-to-event outcome , 2013, BMC Medical Research Methodology.
[11] Bohdana Ratitch,et al. Sensitivity to censored‐at‐random assumption in the analysis of time‐to‐event endpoints , 2016, Pharmaceutical statistics.
[12] D. Rubin. INFERENCE AND MISSING DATA , 1975 .
[13] Lihui Zhao,et al. On the restricted mean survival time curve in survival analysis , 2016, Biometrics.
[14] Bohdana Ratitch,et al. Missing data in clinical trials: from clinical assumptions to statistical analysis using pattern mixture models , 2013, Pharmaceutical statistics.
[15] S. Hammer,et al. A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. AIDS Clinical Trials Group Study 175 Study Team. , 1996, The New England journal of medicine.
[16] Improve-It Investigators. Ezetimibe added to statin therapy after acute coronary syndromes , 2015 .
[17] R. Califf,et al. Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes. , 2015, The New England journal of medicine.
[18] Markus Pauly. Weighted resampling of martingale difference arrays with applications , 2011 .
[19] Min Zhang,et al. Double-robust semiparametric estimator for differences in restricted mean lifetimes in observational studies. , 2012, Biometrics.
[20] Xiao-Li Meng,et al. Multiple-Imputation Inferences with Uncongenial Sources of Input , 1994 .
[21] R. Little,et al. The prevention and treatment of missing data in clinical trials. , 2012, The New England journal of medicine.
[22] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[23] Regina Y. Liu. Bootstrap Procedures under some Non-I.I.D. Models , 1988 .
[24] N. Breslow. Covariance analysis of censored survival data. , 1974, Biometrics.
[25] A. Tsiatis. Semiparametric Theory and Missing Data , 2006 .
[26] R. Little. Pattern-Mixture Models for Multivariate Incomplete Data , 1993 .
[27] R. Prentice,et al. Commentary on Andersen and Gill's "Cox's Regression Model for Counting Processes: A Large Sample Study" , 1982 .
[28] Joseph G Ibrahim,et al. Control-based imputation for sensitivity analyses in informative censoring for recurrent event data. , 2017, Pharmaceutical statistics.
[29] Donglin Zeng,et al. Maximum likelihood estimation in semiparametric regression models with censored data , 2007, Statistica Sinica.
[30] E. Mammen. Bootstrap and Wild Bootstrap for High Dimensional Linear Models , 1993 .
[31] Gary G. Koch,et al. Comparison Between Two Controlled Multiple Imputation Methods for Sensitivity Analyses of Time-to-Event Data With Possibly Informative Censoring , 2015 .
[32] G. Liu,et al. On analysis of longitudinal clinical trials with missing data using reference-based imputation , 2016, Journal of biopharmaceutical statistics.
[33] Miguel A Hernán,et al. The hazards of hazard ratios. , 2010, Epidemiology.
[34] Mouna Akacha,et al. Sensitivity analyses for partially observed recurrent event data , 2016, Pharmaceutical statistics.
[35] James R Carpenter,et al. Analysis of Longitudinal Trials with Protocol Deviation: A Framework for Relevant, Accessible Assumptions, and Inference via Multiple Imputation , 2013, Journal of biopharmaceutical statistics.